These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20386440)

  • 1. The role of antiplatelet therapy in the secondary prevention of coronary artery disease.
    Behan MW; Chew DP; Aylward PE
    Curr Opin Cardiol; 2010 Jul; 25(4):321-8. PubMed ID: 20386440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel in coronary artery disease: update 2012.
    Huber K
    Adv Cardiol; 2012; 47():31-8. PubMed ID: 22906901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiplatelet drugs: beyond aspirin and clopidogrel.
    Siddique A; Butt M; Shantsila E; Lip GY
    Int J Clin Pract; 2009 May; 63(5):776-89. PubMed ID: 19392926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
    White HD
    Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy: boon or bane for high-risk CV patients?
    Phillippe HM; Baty SR; Griffith CB
    J Fam Pract; 2011 Apr; 60(4):187-92. PubMed ID: 21472149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anti-platelet agents: the end of resistance?
    Kastrati A
    Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor (Brilinta)--better than clopidogrel (Plavix)?
    Med Lett Drugs Ther; 2011 Sep; 53(1372):69-70. PubMed ID: 21897348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].
    Schreiber P; Fauchère I; Wyss C
    Praxis (Bern 1994); 2014 Sep; 103(18):1049-58. PubMed ID: 25183612
    [No Abstract]   [Full Text] [Related]  

  • 10. Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development.
    Tomasello SD; Tello-Montoliu A; Angiolillo DJ
    Expert Opin Investig Drugs; 2011 Jan; 20(1):119-33. PubMed ID: 21143003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling the smokers' paradox: cigarette smoking, high-risk coronary artery disease and enhanced clinical efficacy of oral P2Y₁₂ inhibitors.
    Gurbel PA; Baker BA; Bailey WL; Bliden KP; Tantry US
    Thromb Haemost; 2014 Jun; 111(6):1187-90. PubMed ID: 24553730
    [No Abstract]   [Full Text] [Related]  

  • 12. Ideal antiplatelet therapy for coronary artery disease: focus on adenosine diphosphate receptor inhibitors.
    Chandrasekar S; Loomba R; Shah P; Arora R
    Am J Ther; 2013; 20(4):337-43. PubMed ID: 21519219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
    Oprea AD; Popescu WM
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):779-95. PubMed ID: 23648080
    [No Abstract]   [Full Text] [Related]  

  • 14. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?
    Kern MJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern antiplatelet agents in coronary artery disease.
    Power RF; Hynes BG; Moran D; Yagoub H; Kiernan G; Ruggiero NJ; Kiernan TJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1261-72. PubMed ID: 23190065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antiplatelet therapy for acute coronary syndromes.
    Contractor H; Ruparelia N
    Postgrad Med J; 2012 Jul; 88(1041):391-6. PubMed ID: 22357775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antiplatelet agents in patients with atherosclerotic disease.
    Acharji S; Lakshmanadoss U; Rudzinski W; Stapleton DD; Kaluski E
    Postgrad Med; 2013 Sep; 125(5):19-30. PubMed ID: 24113660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ticagrelor in clopidogrel nonresponders: resistance is futile?
    Tapp L; Shantsila E; Lip GY
    Circulation; 2010 Mar; 121(10):1169-71. PubMed ID: 20194888
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual antiplatelet therapy in coronary artery disease: a case-based approach.
    Raymond C; Menon V
    Cleve Clin J Med; 2009 Nov; 76(11):663-70. PubMed ID: 19884296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor for the treatment of arterial thrombosis.
    Gurbel PA; Kereiakes DJ; Tantry US
    Expert Opin Pharmacother; 2010 Sep; 11(13):2251-9. PubMed ID: 20707759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.